| B11 | Outcomes and incidence of TB among people living with HIV who received TB preventive therapy in Uganda | On-demand oral abstract session | Tuberculosis and other mycobacteria |
| B11 | Correlates associated with mortality among HIV-TB co-infected patients in Mumbai, India | On-demand oral abstract session | Tuberculosis and other mycobacteria |
| B11 | Long-term survival and predictors of mortality in HIV/TB patients in Uganda | On-demand oral abstract session | Tuberculosis and other mycobacteria |
| B11 | Early termination of randomisation into TB-PRACTECAL, a novel six months all-oral regimen Drug Resistant TB study | Oral abstract session with live Q&A | Tuberculosis and other mycobacteria |
| B11 | High rate of successful outcomes treating highly resistant TB in the ZeNix study of pretomanid, bedaquiline and alternative doses and durations of linezolid | Oral abstract session with live Q&A | Tuberculosis and other mycobacteria |
| B11 | Gender differences among patients with drug resistant tuberculosis and HIV co-infection in Uganda: a countrywide retrospective cohort study | E-poster | Tuberculosis and other mycobacteria |
| B11 | Investigating isoniazid prevention therapy completion rate among adult HIV patients on antiretroviral therapy and its effectiveness in preventing tuberculosis at Katutura Hospital, Namibia, 2014-2018 | E-poster | Tuberculosis and other mycobacteria |
| B12 | Epidemiological trends of hepatitis B morbidity and mortality in Greece, Italy, Portugal and Spain, 2000-2019: a systematic analysis from the Global Burden of Disease Study 2019 | E-poster | Viral hepatitis A, B, D and E |
| B12 | Molecular diversity of hepatitis B virus in HIV infected patients at Mbagathi District Hospital, Nairobi | E-poster | Viral hepatitis A, B, D and E |
| B13 | High HCV cure rates in C-FREE, first community-based study offering testing and treatment of viral hepatitis and HIV among people who use drugs and their partners in Thailand | On-demand oral abstract session | Viral hepatitis C |